NUGX — Nugenerex Immuno-Oncology Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $1.63m
Annual balance sheet for Nugenerex Immuno-Oncology, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 0.001 | 0 | 0 |
| Total Current Assets | 0.001 | 0 | 0 |
| Total Assets | 0.001 | 0 | 0 |
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Current Liabilities | 3.66 | 4.38 | 5.84 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 3.66 | 4.38 | 5.84 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -3.66 | -4.38 | -5.84 |
| Total Liabilities & Shareholders' Equity | 0.001 | 0 | 0 |